Iron chelation in early Parkinson's disease

Lancet Neurol. 2023 Apr;22(4):290-291. doi: 10.1016/S1474-4422(23)00039-X.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Iron Chelating Agents / therapeutic use
  • Parkinson Disease* / drug therapy
  • Substantia Nigra

Substances

  • Iron Chelating Agents